Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Revenio Group, headquartered in Finland, is a globally operating health technology company. It specializes in innovative medical technology for ophthalmology, particularly precise devices for glaucoma diagnostics. The company enhances the early detection of ophthalmic diseases worldwide.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Revenio Group is scheduled to report its next quarterly earnings on 11/12/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Revenio Group last reported quarterly earnings on 9/8/2026 (Q2 2026). Earnings per share (EPS) came in at 0.02 EUR.
Across its last 5 earnings reports, Revenio Group stock moved by ±8.8% on average the following day. The largest reaction was -17.8% on 09/08/2026; 0 of 5 reactions were positive.
Revenio Group has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.